These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6377070)

  • 21. Reduction of infarct size with the early use of timolol in acute myocardial infarction.
    International Collaborative Study Group
    N Engl J Med; 1984 Jan; 310(1):9-15. PubMed ID: 6358896
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of nifedipine on enzymatically estimated infarct size in the early phase of acute myocardial infarction.
    Walker LJ; MacKenzie G; Adgey AA
    Br Heart J; 1988 Apr; 59(4):403-10. PubMed ID: 3285877
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protective effect of propranolol in threatened myocardial infarction.
    Norris RM; Clarke ED; Sammel NL; Smith WM; Williams B
    Lancet; 1978 Oct; 2(8096):907-9. PubMed ID: 81925
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beneficial effects of timolol on infarct size and late ventricular tachycardia in patients with acute myocardial infarction.
    Roqué F; Amuchastegui LM; Lopez Morillos MA; Mon GA; Girotti AL; Drajer S; Fortunato M; Moreyra E; Tuero P; Solchaga JC
    Circulation; 1987 Sep; 76(3):610-7. PubMed ID: 3304706
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hyaluronidase therapy for acute myocardial infarction: results of a randomized, blinded, multicenter trial. MILIS Study Group.
    Am J Cardiol; 1986 Jun; 57(15):1236-43. PubMed ID: 2872794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myocardial infarction in the dog: effects of intravenous propranolol.
    Fox K; Welman E; Selwyn A
    Am J Cardiol; 1980 Apr; 45(4):769-74. PubMed ID: 7361667
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of early administration of a highly purified hyaluronidase preparation (GL enzyme) on myocardial infarct size.
    Saltissi S; Robinson PS; Coltart DJ; Webb-Peploe MM; Croft DN
    Lancet; 1982 Apr; 1(8277):867-71. PubMed ID: 6122098
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of early treatment with propranolol on left ventricular function four weeks after myocardial infarction.
    Brown MA; Norris RM; Barnaby PF; Geary GG; Brandt PW
    Br Heart J; 1985 Oct; 54(4):351-6. PubMed ID: 4052276
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of very early intervention with metoprolol on myocardial infarct size.
    Boyle DM; Barber JM; McIlmoyle EL; Salathia KS; Evans AE; Cran G; Elwood JH; Shanks RG
    Br Heart J; 1983 Mar; 49(3):229-33. PubMed ID: 6338889
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evolution of infarct size during the early use of nifedipine in patients with acute myocardial infarction: the Norwegian Nifedipine Multicenter Trial.
    Sirnes PA; Overskeid K; Pedersen TR; Bathen J; Drivenes A; Frøland GS; Kjekshus JK; Landmark K; Rokseth R; Sirnes KE
    Circulation; 1984 Oct; 70(4):638-44. PubMed ID: 6383655
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intravenous hyaluronidase therapy for myocardial infarction in man: double-blind trial to assess infarct size limitation.
    Cairns JA; Holder DA; Tanser P; Missirlis E
    Circulation; 1982 Apr; 65(4):764-71. PubMed ID: 7060255
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravenous propranolol therapy for acute myocardial infarction in man: hemodynamic and serial creatine kinase assessment.
    Cairns JA; Klassen GA
    Chest; 1981 Mar; 79(3):277-85. PubMed ID: 7471859
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Limitation of myocardial infarct size in patients less than 66 years treated with alprenolol.
    Jürgensen JH; Frederiksen J; Hansen DA; Pedersen-Bjergaard O
    Br Heart J; 1981 May; 45(5):583-8. PubMed ID: 7016150
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early intervention with propranolol after acute myocardial infarction: serial left ventricular function determined by M-mode and cross-sectional echocardiography.
    Kaul UA; Verma R; Garg KC
    Int J Cardiol; 1988 Dec; 21(3):301-10. PubMed ID: 3229867
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized clinical trial of intravenous nitroglycerin in patients with acute myocardial infarction: benefits of early treatment.
    Flaherty JT; Becker LC; Bulkley BH; Weiss JL; Gerstenblith G; Kallman CH; Pitt B; Weisfeldt ML
    Z Kardiol; 1983; 72 Suppl 3():131-6. PubMed ID: 6421004
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term follow-up after acute myocardial infarction in patients randomized to treatment with intravenous magnesium or intravenous propranolol in the acute phase.
    Abraham AS; Balkin J; Rosenmann D; Ilan M; Klutstein M; Zion MM
    Magnes Res; 1994 Dec; 7(3-4):273-6. PubMed ID: 7786690
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of double-blindness at the conclusion of the beta-Blocker Heart Attack Trial.
    Byington RP; Curb JD; Mattson ME
    JAMA; 1985 Mar 22-29; 253(12):1733-6. PubMed ID: 3974051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Importance of heart rate in determining beta-blocker efficacy in acute and long-term acute myocardial infarction intervention trials.
    Kjekshus JK
    Am J Cardiol; 1986 Apr; 57(12):43F-49F. PubMed ID: 2871745
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute myocardial infarct size reduction by timolol administration. The International Collaborative Study Group.
    Am J Cardiol; 1986 Apr; 57(12):28F-33F. PubMed ID: 2871742
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A prospective randomized trial of intravenous magnesium versus intravenous propranolol in acute myocardial infarction.
    Balkin J; Rosenmann D; Ilan M; Klutstein M; Zion MM; Abraham AS
    Magnes Res; 1994 Dec; 7(3-4):267-71. PubMed ID: 7786689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.